Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
Pre-Market
In 23 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a US biotechnology company specializing in molecular glue degraders. These small molecules trigger the targeted destruction of disease-causing proteins, with a focus on oncology and immune-mediated diseases.
Frequently asked questions
When will Monte Rosa Therapeutics report its next quarterly earnings?
Monte Rosa Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Monte Rosa Therapeutics last report quarterly earnings?
Monte Rosa Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.43 USD.
How does Monte Rosa Therapeutics stock react to earnings?
Across its last 3 earnings reports, Monte Rosa Therapeutics stock moved by ±1.8% on average the following day. The largest reaction was -2.8% on 05/07/2026; 1 of 3 reactions were positive.
How often has Monte Rosa Therapeutics beaten expectations?
Monte Rosa Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Monte Rosa Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Stock reaction to earnings
±1.8%
Avg. next-day move
-2.8%
Largest move (05/07/2026)
33.3%
Share of positive reactions
±6.6%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
-16.4%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Monte Rosa Therapeutics
Country
🇺🇸
More Financial Information